Dr. Sarvenaz Alibeigi, MD

Dr. Alibeigi practices at Pacific Inpatient Medical Group in San Francisco, California.

Dr. Alibeigi's NPI, 1639504251, was assigned on September 13, 2013. Dr. Alibeigi graduated from St. George's University School of Medicine in 2012. Dr. Alibeigi holds California license A132182.

Dr. Alibeigi's primary practice is Pacific Inpatient Medical Group, at 601 Van Ness Ave, San Francisco, CA 94102 in San Francisco County. The practice phone is (415) 531-9047.

Dr. Alibeigi's primary practice is Pacific Inpatient Medical Group in San Francisco, California. Dr. Alibeigi is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is Pacific Inpatient Medical Group. Dmand AI also links Dr. Alibeigi to 3 more medical groups, 2 group practices and clinics, 2 hospices and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alibeigi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alibeigi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Alibeigi is board certified in internal medicine by the American Board of Internal Medicine. Dr. Alibeigi is licensed in California.

Dmand AI lists anemia, cardiac arrhythmia, congestive heart failure, electrolyte disorders, gastrointestinal bleeding, gastrointestinal obstruction, heart attack and kidney stones among the conditions Dr. Alibeigi treats.

CMS data shows 954 Medicare services from Dr. Alibeigi across 6 procedure codes in 2024, for 341 Medicare patients. Medicare paid $68,081 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 341 Medicare patients who saw Dr. Alibeigi in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alibeigi's median patient age at 76, with 57% women.

In 2024, Dr. Alibeigi wrote 345 Medicare Part D claims for 133 patients. 90% of them were for generic drugs. CMS names the drug for 97 of them, across 6 drugs with 11 or more claims each, at $9,866 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Alibeigi for performance year 2024, reported as part of a group. Dr. Alibeigi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Alibeigi from 2 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 64% of the total. AstraZeneca Pharmaceuticals LP paid the most, $100.

Dr. Alibeigi graduated from St. George's University School of Medicine in 2012.

Dr. Alibeigi is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and HCSC. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.